US proposal to halve biosimilar development costs for India's Biocon, top exec says
India's Biocon expects a 50% drop in costs for developing complex biosimilars as the United States has proposed to ease clinical testing for the drugs that make up more
November 13, 2025
What to expect in New Jersey's special congressional primary
Edmunds puts sedans Nissan Sentra and Toyota Corolla to the test
IOC open to earlier dates for future Winter Olympics and Paralympics because of warmer temperatures
Russia and Ukraine envoys meet in Abu Dhabi for US-brokered talks
Meet the world’s fastest skier
One year on from dismantling of USAID, study projects that global aid cuts could lead to 9.4 million deaths by 2030
Super Bowl LX ads feature AI, weight-loss drugs and celebs from George Clooney to Kendall Jenner